The move is part of the company's efforts to consolidate the shareholding of various promoters.
As many as 3.84 crore shares were transferred to Athanas Enterprises and Abellon Energy, the two promoters of pharma company.
According to bulk deal data available with the BSE, Claris Lifesciences' four promoters--Aditya S Handa, Arjun Handa, Medical Technologies and Sarjan Financial--transfered a total of 3.84 crore shares, amounting to 60.21 per cent, of the company worth Rs 801 crore.
Besides, Medical Technologies has transfered 46.53 lakh, while Sarjan Financial has shifted 2.37 crore scrips of Claris Lifesciences at a price of Rs 204.7 per share.
Also Read
Of total 60.2 per cent shares transfered, 49.48 per cent holding has been acquired by Athanas Enterprises and the remaining 10.72 per cent by Abellon Energy.
As of September quarter, the promoters along with Arjun Handa held 60.21 per cent stake or 3.84 crore shares in the company.
Claris Lifesciences shares fell by 2.09 per cent to close at Rs 194.30 apiece on the BSE.